Table 3.

Prognosis of 10 patients with neuroblastoma

Case	Conventional treatment*	Time to first progression or recurrence	Site of first progression or recurrence	Postprogression or recurrence treatment	Prognosis	Survival period (months)
1	Chemotherapy-surgery-chemotherapy	/	/	/	Tumor-free survival	62
2	Chemotherapy-surgery	5 months after treatment initiation	Brain, lung, bone marrow, bone, distant lymph nodes, liver	Chemotherapy-surgery†	Death	17
3	Chemotherapy-surgery-chemotherapy	15 months after treatment initiation	Liver	Chemotherapy	Death	17
4	Chemotherapy-surgery-chemotherapy-surgery‡-radiotherapy-chemotherapy	16 months after treatment initiation	Liver	Chemotherapy	Death	28
5	Chemotherapy-surgery-chemotherapy	7 months after treatment initiation	Primary site, bone	Chemotherapy	Death	12
6	Emergency surgery§-chemotherapy-surgery-chemotherapy	34 months after treatment initiation	Brain	Chemotherapy	Death	36
7	Chemotherapy-surgery-chemotherapy-GD2 immunotherapy	44 months after treatment initiation	Bone, distant lymph nodes	Chemotherapy-DFMO	Death	64
8	Chemotherapy-surgery-chemotherapy-surgery¶-radiotherapy	9 months after treatment initiation	Primary site, lung, bone	Chemotherapy	Death	19
9	Chemotherapy	1 month after treatment initiation	Primary site, lung, liver	Chemotherapy-surgery	Death	6
10	Chemotherapy	1 month after treatment initiation	Lung	Chemotherapy-surgery-surgery**	Death	5

*Unless otherwise specified, ‘surgery’ refers to resection of the primary tumor.

†Wedge resection of the right middle lobe of the lung.

‡Resection of residual retroperitoneal tumor.

§Microsurgical resection of extradural tumor.

¶Resection of residual retroperitoneal and mediastinal tumors plus dissection of distant lymph nodes.

**Resection of the primary tumor and tumors in the right mediastinum and chest wall.

DFMO, difluoromethylornithine.